E-LIB Suche - Ergebnisse für: Schjesvold, F

1

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREA..:

van de Donk, N. ; Minnema, M.C. ; van der Holt, B....
HemaSphere. 7 (2023) S2 - p. 4-5 , 2023

Link: https://doi.org/10.1097/..

2

P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY ..:

Schjesvold, F ; Ludwig, H ; Delimpasi, S...
HemaSphere. 7 (2023) S2 - p. 32-32 , 2023

Link: https://doi.org/10.1097/..

3

P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) ..:

Mateos, M ; Szarejko, M ; Bila, J...
HemaSphere. 7 (2023) S2 - p. 29-30 , 2023

Link: https://doi.org/10.1097/..

4

P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAP..:

Slørdahl, T. S. ; Askeland, F. B. ; Hanssen, M. S. S....
HemaSphere. 6 (2022) - p. 840-841 , 2022

Link: https://doi.org/10.1097/..

5

P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHA..:

Raab, M. S. ; Cohen, Y. C. ; Schjesvold, F....
HemaSphere. 6 (2022) - p. 827-828 , 2022

Link: https://doi.org/10.1097/..

6

P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PAT..:

Askeland, F. B. ; Rasmussen, A.-M. ; Lysen, A....
HemaSphere. 6 (2022) - p. 781-782 , 2022

Link: https://doi.org/10.1097/..

7

P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE ..:

Askeland, F. B. ; Haukås, E. ; Slørdahl, T. S....
HemaSphere. 6 (2022) - p. 780-781 , 2022

Link: https://doi.org/10.1097/..

8

P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION ..:

Nørgaard, J. N. ; Abildgaard, N. ; Lysén, A....
HemaSphere. 6 (2022) - p. 828-829 , 2022

Link: https://doi.org/10.1097/..

9

P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALI..:

Oriol, A. ; Dimopoulos, M. ; Schjesvold, F....
HemaSphere. 6 (2022) - p. 792-793 , 2022

Link: https://doi.org/10.1097/..

10

Autologous bone marrow Th cells can support multiple myelom..:

Wang, D ; Fløisand, Y ; Myklebust, C V...
Leukemia. 31 (2017) 10 - p. 2114-2121 , 2017

Link: https://doi.org/10.1038/..

11

P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED..:

Groen, K. ; Seefat, M. R. ; van der Holt, B....
HemaSphere. 6 (2022) - p. 796-797 , 2022

Link: https://doi.org/10.1097/..

12

EE73 Ocean (OP-103): Patients with Relapsed/Refractory Mult..:

Hellem Schjesvold, F. ; Ludwig, H. ; Delimpasi, S....
Value in Health. 26 (2023) 12 - p. S64 , 2023

Link: https://doi.org/10.1016/..

13

P53 Patient Preferences for Multiple Myeloma Treatment: A S..:

Janssens, R. ; Lang, T. ; Vallejo, A....
Value in Health. 25 (2022) 7 - p. S298 , 2022

Link: https://doi.org/10.1016/..

14

P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY ..:

Schjesvold, F ; Ludwig, H ; Delimpasi, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171472/. , 2023

Link: http://www.ncbi.nlm.nih...

15

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREA..:

van de Donk, N ; Minnema, M.C ; van der Holt, B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171678/. , 2023

Link: http://www.ncbi.nlm.nih...